Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo In the U.S., there are more than ...

If approved for an expanded pediatric indication, AJOVY would be the first calcitonin gene-related peptide (CGRP) antagonist for migraine ...

If approved for an expanded pediatric indication, AJOVY would be the first calcitonin gene-related peptide (CGRP) antagonist for migraine prevention in adults and episodic migraine prevention in pedia ...

LOUIS, April 02, 2025 (GLOBE NEWSWIRE) -- Curium announced today that the U.S. Food and Drug Administration approved its generic version of the Kit for the Preparation of Technetium Tc 99m Pentetate ...

The FDA has approved fitusiran, now Qfitlia, as a treatment for hemophilia A or B patients, ages 12 and older, with or without inhibitors.

Ozempic is not FDA approved for any uses in children. Your doctor can recommend ... Both drugs come as a solution that’s given as a subcutaneous injection. Your doctor will show you or a ...

Merck MRK announced that the FDA has accepted its regulatory filing seeking approval for the subcutaneous (under the skin or SC) formulation of the blockbuster drug Keytruda (pembrolizumab).

formulation associated with a new route of administration (subcutaneous use), a new pharmaceutical form (solution for injection) and a new strength (600 mg/vial). Nivolumab for subcutaneous use co ...

Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad ...

Recent airplane accidents have fueled concerns about whether young children are sufficiently protected on flights and prompted parents and caregivers to re-evaluate how, and even whether ...

And “Audrey’s Children” reminds us that as recently as the late 1960s, the survival rate for children with cancer was just 10 percent compared to almost 90 percent today. It is the story of Dr. Audrey ...

Early-life exposure to antibiotics can disrupt the growth of insulin-producing cells in the pancreas by altering the infant microbiome, increasing the risk of diabetes later on, according to new mouse ...